Cisco Systems, Inc.
Cisco Systems, Inc. (CSCO) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Cisco Systems, Inc. (CSCO), featuring income statements, balance sheets, and cash flow data.
Cisco Systems, Inc. (CSCO) Income Statement & Financial Overview
Explore comprehensive income reports for Cisco Systems, Inc. CSCO, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $13.99B | $13.84B | $13.64B | $12.70B |
| Cost of Revenue | $4.88B | $4.72B | $4.86B | $4.61B |
| Gross Profit | $9.11B | $9.12B | $8.78B | $8.09B |
| Gross Profit Ratio | $0.65 | $0.66 | $0.64 | $0.64 |
| R&D Expenses | $2.30B | $2.29B | $2.18B | $1.95B |
| SG&A Expenses | $3.42B | $3.55B | $3.60B | $3.26B |
| Operating Expenses | $6.00B | $5.83B | $6.16B | $5.33B |
| Total Costs & Expenses | $10.60B | $11.48B | $11.02B | $9.94B |
| Interest Income | $238.00M | $286.00M | $270.00M | $411.00M |
| Interest Expense | $404.00M | $418.00M | $418.00M | $357.00M |
| Depreciation & Amortization | $761.00M | $789.00M | $823.00M | $861.00M |
| EBITDA | $4.05B | $3.47B | $3.64B | $3.45B |
| EBITDA Ratio | $0.29 | $0.25 | $0.27 | $0.27 |
| Operating Income | $3.11B | $2.36B | $2.62B | $2.77B |
| Operating Income Ratio | $0.22 | $0.17 | $0.19 | $0.22 |
| Other Income/Expenses (Net) | -$226.00M | -$91.00M | -$222.00M | $44.00M |
| Income Before Tax | $2.89B | $2.27B | $2.40B | $2.23B |
| Income Before Tax Ratio | $0.21 | $0.16 | $0.18 | $0.18 |
| Income Tax Expense | $459.00M | -$444.00M | $234.00M | $349.00M |
| Net Income | $2.43B | $2.71B | $2.16B | $1.89B |
| Net Income Ratio | $0.17 | $0.20 | $0.16 | $0.15 |
| EPS | $0.61 | $0.68 | $0.54 | $0.47 |
| Diluted EPS | $0.61 | $0.68 | $0.54 | $0.46 |
| Weighted Avg Shares Outstanding | $3.98B | $3.99B | $4.02B | $4.04B |
| Weighted Avg Shares Outstanding (Diluted) | $4.005B | $4.01B | $4.04B | $4.06B |
Over the past four quarters, Cisco Systems, Inc. demonstrated steady revenue growth, increasing from $12.70B in Q3 2024 to $13.99B in Q2 2025. Operating income reached $3.11B in Q2 2025, maintaining a consistent 22% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $4.05B, reflecting operational efficiency. Net income dropped to $2.43B, with EPS at $0.61. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan